At 36, are my symptoms related to psoriatic arthritis?

Question

Hello doctor,

I am a 36-year-old woman with moderate-to-severe plaque psoriasis, especially on my elbows, knees, and lower back. Recently, I have noticed morning joint stiffness and swelling in my fingers and wrists that takes over an hour to go away. My dermatologist mentioned this might be psoriatic arthritis. I am currently using topical steroids and phototherapy, but the skin symptoms are getting worse, and joint pain is affecting my work. Please tell me;

Could this be early psoriatic arthritis?
What kind of investigations confirm it?
Could you explain long-term treatment options, especially biologics, including their safety, cost, and monitoring needs?

Kindly help.

Answer 1

Hello,

Welcome to icliniq.com.

I read your query and can understand your concern.

Given your history of moderate-to-severe plaque psoriasis and new symptoms of prolonged morning joint stiffness, swelling in your fingers and wrists, and worsening skin lesions despite topical steroids and phototherapy, you may be developing early psoriatic arthritis (PsA).

PsA is an inflammatory joint disease that affects around 20 to 30 percent of people with psoriasis, and early detection is important to prevent permanent joint damage. Diagnosis is made through a combination of clinical evaluation and the following blood tests,

Blood tests such as ESR (erythrocyte sedimentation rate) and CRP (C-reactive protein) to check for inflammation, rheumatoid factor, and anti-CCP (Anti-Cyclic Citrullinated Peptide) to rule out rheumatoid arthritis.
Kidney and liver function tests.
Imaging, like X-rays, can detect later joint changes, but ultrasound or MRI is more sensitive for early inflammation in joints and tendon attachments.

A rheumatologist will use these findings along with your psoriasis history to confirm PsA, often following the CASPAR (Classification criteria for psoriatic arthritis) criteria.

In case of your mild symptoms, you may need NSAIDs (non-steroidal anti-inflammatory drugs) and local steroid injections, but persistent or more severe disease usually needs systemic treatment.

Conventional disease-modifying anti-rheumatic drugs like Methotrexate, Sulfasalazine, or Leflunomide are often first-line drugs.

However, if these are insufficient for you, biologics or targeted synthetic drugs are introduced. Biologics are advanced treatments that block specific immune pathways, effectively controlling both skin and joint inflammation. Common classes include

TNF (tumor necrosis factor) inhibitors like Adalimumab and Etanercept.
IL-17(interleukins) inhibitors like Secukinumab and Ixekizumab.
IL-12/23 inhibitors like Ustekinumab, and IL-23 inhibitors Such as Guselkumab, Risankizumab.

Each differs in dosing frequency, speed of effect, and side-effect profile. Before starting these drugs, screening for tuberculosis and hepatitis B/C is essential, as well as updating vaccinations. Regular monitoring with blood tests every 3–6 months helps track safety, especially for your infection risks and organ function issues.

I hope this information helps you.

Feel free to ask further queries.

Thank you.